XML 88 R68.htm IDEA: XBRL DOCUMENT v3.21.2
Long-term Investments - Equity Method Investments (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Schedule Of Equity Method Investment [Roll Forward]        
Beginning balance     $ 3,783  
Addition     24,914  
Income (loss) on investment $ (819) $ 7 (1,517) $ (8)
Reclassification to equity method investee     250  
Reclassification to subsidiaries     (2,372)  
Dilution loss due to investee share issuance     (31)  
Ending balance 25,027   25,027  
Energica        
Schedule Of Equity Method Investment [Roll Forward]        
Beginning balance     0  
Addition     13,555  
Income (loss) on investment     (735)  
Reclassification to equity method investee     0  
Reclassification to subsidiaries     0  
Dilution loss due to investee share issuance     0  
Ending balance 12,820   12,820  
Solectrac        
Schedule Of Equity Method Investment [Roll Forward]        
Beginning balance     2,556  
Addition     0  
Income (loss) on investment     (153)  
Reclassification to equity method investee     0  
Reclassification to subsidiaries     (2,372)  
Dilution loss due to investee share issuance     (31)  
Ending balance 0   0  
FNL Technologies        
Schedule Of Equity Method Investment [Roll Forward]        
Beginning balance     0  
Addition     3,505  
Income (loss) on investment     (236)  
Reclassification to equity method investee     250  
Reclassification to subsidiaries     0  
Dilution loss due to investee share issuance     0  
Ending balance 3,519   3,519  
MDI Fund        
Schedule Of Equity Method Investment [Roll Forward]        
Beginning balance     0  
Addition     628  
Income (loss) on investment     0  
Reclassification to equity method investee     0  
Reclassification to subsidiaries     0  
Dilution loss due to investee share issuance     0  
Ending balance 628   628  
TM2        
Schedule Of Equity Method Investment [Roll Forward]        
Beginning balance     1,227  
Addition     7,226  
Income (loss) on investment     (393)  
Reclassification to equity method investee     0  
Reclassification to subsidiaries     0  
Dilution loss due to investee share issuance     0  
Ending balance $ 8,060   $ 8,060